Notice of Results and Investor Presentation
Shareholder Information
Shares In Issue
The number of ordinary shares of the Company in issue is 158,166,666, with approximately 34% deemed to be in public hands.
Significant Shareholders
The Company has been notified of the following interests of 5% or more in the issued ordinary share capital of the Company
| Number | Ordinary Shares % | |
|---|---|---|
| OptiBiotix | 53,533,333 | 33.85% |
| Holdingselskabet of 29. Juni 2010 Aps. | 33,160,000 | 20.97% |
| Seneca Partners Limited | 8,025,450 | 5.07% |
Directors' Shareholders
| Number | Ordinary Share % | |
|---|---|---|
| Stephen O'Hara | 6,131,450 | 3.88% |
| Frederik Bruhn-Petersen | 3,000,000 | 1.90% |
| Adam Reynolds | 142,857 | 0.09% |
Restrictions on transfer of the Company's Securities
There are no restrictions on the transfer of ProBiotix Health plc's Aquis Exchange securities.
UK City Code on Takeovers and Mergers
ProBiotix Health plc is subject to the UK City Code on Takeovers and Mergers.
Other exchanges and trading platforms
ProBiotix Health plc has not applied or agreed to have any of it securities (including its Aquis Exchange securities) admitted or traded on any other exchanges or trading platforms.
Shareholder Circulars
| Date | Document |
|---|---|
| 15 October 2024 | Notice of Requisitioned General Meeting to be held on 01 November 2024 |
| 08 August 2024 | Proxy results for the AGM held on 08 August 2024 |
| 28 June 2024 | Notice of Annual General Meeting to be held on 8 August 2024 |
| 26 July 2023 | Proxy results for the AGM held on 26 July 2023 |
| 28 June 2023 | Notice of Annual General Meeting held on 26 July 2023 |
| Proxy for the Annual General Meeting held on 26 July 2023 |
Latest RNS News
Latest Interview
Aquis-listed ProBiotix Health taps into demand for cardiovascular disease treatments
Stephen O'Hara | 23 February 2023
IG UK | Youtube